Are you over 18 and want to see adult content?
More Annotations
A complete backup of https://imbored-letsgo.com
Are you over 18 and want to see adult content?
A complete backup of https://kaigo-kyuujin.com
Are you over 18 and want to see adult content?
A complete backup of https://roseltorg.ru
Are you over 18 and want to see adult content?
A complete backup of https://fidefundacion.es
Are you over 18 and want to see adult content?
A complete backup of https://puramaryam.de
Are you over 18 and want to see adult content?
A complete backup of https://phytojournal.com
Are you over 18 and want to see adult content?
A complete backup of https://vision-mobility.de
Are you over 18 and want to see adult content?
A complete backup of https://okura-nikko.com
Are you over 18 and want to see adult content?
A complete backup of https://ipadizate.es
Are you over 18 and want to see adult content?
A complete backup of https://inspiretec.com
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of woodbridgecenter.com
Are you over 18 and want to see adult content?
A complete backup of sperlinggrove.blogspot.com
Are you over 18 and want to see adult content?
Text
COMPANY | STADA
The STADA Group. At STADA, we follow our purpose of “Caring for people’s health as a trusted partner”. In pursuit of this purpose, we are committed to further accelerating the successful trajectory of our company. STADA is a leading manufacturer of high-quality pharmaceuticals. With a long-standing heritage rooted in pharmacies,we are
ANNUAL REPORT 2020
A message from Peter Goldschmidt, CEO. 2020 was for each of us a demanding year. Like all of you, we at STADA had to deal with new challenges and to adapt to OUR CORPORATE CULTURE This was the beginning of STADA’s impressive development. We are a leading manufacturer of high-quality pharmaceuticals. With a long-standing heritage rooted in pharmacies, we are a reliable and trustworthy partner for more than 120 years. With our products, we help people protect and regain a dignified and able life.LADIVAL | STADA
Ladival® Active. • Suitable for active individuals, who are always on the move/play sports, to provide sun protection. • Comes as spray, crème and stick; free from perfume, artificial colours, preservatives. Ladival® Acute – calming lotion. • Suitable for soothing redness and burn caused by the sun by repairing cellular DNAdamage.
LIDERIN® | STADA
Liderin® is a product for men. Its natural ingredients support sexual performance. It is a combination of ingredients of natural origin and essentials vitamins. GESCHÄFTSBERICHT 2020 Lieferfähigkeit. Währungsbereinigter Umsatz 2020 3.010,3 Mio. €. Währungsbereinigtes EBITDA +15% in 2020. Operative Cash Flow 71% Cash Conversion Rate. Compliance unverändert: behördliche Inspektionen im Jahr 2020. Sicherheit in den Produktionsstätten gestiegen. STADA: NEUARTIGE THERAPIE ZUR BEHANDLUNG VON …TRANSLATE THIS PAGE STADA führt neuartige Therapie zur Behandlung von Parkinson in Deutschland und Österreich ein. Im Oktober erwarb STADA die Rechte für ein Dreifach-Kombipräparat mit den Wirkstoffen Levodopa, Carbidopa, Entacapon, das zur Behandlung von Parkinson im fortgeschrittenen Stadium nun in Deutschland und Österreicheingeführt wird.
STADA FÜHRT MEDIZINISCHES CANNABIS EIN STADA führt medizinisches Cannabis zur Therapie bei chronischen Schmerzpatienten ein. Als eines der größten Pharmaunternehmen in Deutschland trägt STADA ab sofort mit medizinischem Cannabis zur Versorgung von insbesondere chronischen Schmerzpatienten bei und bietet damit eine ergänzende Therapiemöglichkeit an. STADA ACQUIRES UK BRANDED PRODUCT COMPANY NATURES AID STADA UK Holdings acquires Natures Aid, a privately-owned UK based branded product company, for a purchase price of GBP 18.5 million, including a net cash position of above GBP 1.5m. The company is an established manufacturer of vitamins, minerals, food supplements and herbal products distributed under the Natures Aid brand. STADA ARZNEIMITTEL AG Coronavirus Information Center. The world has changed fighting the coronavirus disease (COVID-19). Our purpose “Caring for people's health as a trusted partner” is more valid than ever. Read more in our information hub about STADA's focus on keep supplying medicines to ensure patients get the medicines they need, intiatives and sources.COMPANY | STADA
The STADA Group. At STADA, we follow our purpose of “Caring for people’s health as a trusted partner”. In pursuit of this purpose, we are committed to further accelerating the successful trajectory of our company. STADA is a leading manufacturer of high-quality pharmaceuticals. With a long-standing heritage rooted in pharmacies,we are
ANNUAL REPORT 2020
A message from Peter Goldschmidt, CEO. 2020 was for each of us a demanding year. Like all of you, we at STADA had to deal with new challenges and to adapt to OUR CORPORATE CULTURE This was the beginning of STADA’s impressive development. We are a leading manufacturer of high-quality pharmaceuticals. With a long-standing heritage rooted in pharmacies, we are a reliable and trustworthy partner for more than 120 years. With our products, we help people protect and regain a dignified and able life.LADIVAL | STADA
Ladival® Active. • Suitable for active individuals, who are always on the move/play sports, to provide sun protection. • Comes as spray, crème and stick; free from perfume, artificial colours, preservatives. Ladival® Acute – calming lotion. • Suitable for soothing redness and burn caused by the sun by repairing cellular DNAdamage.
LIDERIN® | STADA
Liderin® is a product for men. Its natural ingredients support sexual performance. It is a combination of ingredients of natural origin and essentials vitamins. GESCHÄFTSBERICHT 2020 Lieferfähigkeit. Währungsbereinigter Umsatz 2020 3.010,3 Mio. €. Währungsbereinigtes EBITDA +15% in 2020. Operative Cash Flow 71% Cash Conversion Rate. Compliance unverändert: behördliche Inspektionen im Jahr 2020. Sicherheit in den Produktionsstätten gestiegen. STADA: NEUARTIGE THERAPIE ZUR BEHANDLUNG VON …TRANSLATE THIS PAGE STADA führt neuartige Therapie zur Behandlung von Parkinson in Deutschland und Österreich ein. Im Oktober erwarb STADA die Rechte für ein Dreifach-Kombipräparat mit den Wirkstoffen Levodopa, Carbidopa, Entacapon, das zur Behandlung von Parkinson im fortgeschrittenen Stadium nun in Deutschland und Österreicheingeführt wird.
STADA FÜHRT MEDIZINISCHES CANNABIS EIN STADA führt medizinisches Cannabis zur Therapie bei chronischen Schmerzpatienten ein. Als eines der größten Pharmaunternehmen in Deutschland trägt STADA ab sofort mit medizinischem Cannabis zur Versorgung von insbesondere chronischen Schmerzpatienten bei und bietet damit eine ergänzende Therapiemöglichkeit an. STADA ACQUIRES UK BRANDED PRODUCT COMPANY NATURES AID STADA UK Holdings acquires Natures Aid, a privately-owned UK based branded product company, for a purchase price of GBP 18.5 million, including a net cash position of above GBP 1.5m. The company is an established manufacturer of vitamins, minerals, food supplements and herbal products distributed under the Natures Aid brand.COMPANY | STADA
The STADA Group. At STADA, we follow our purpose of “Caring for people’s health as a trusted partner”. In pursuit of this purpose, we are committed to further accelerating the successful trajectory of our company. STADA is a leading manufacturer of high-quality pharmaceuticals. With a long-standing heritage rooted in pharmacies,we are
JOBS & CAREER
Caring for the well-being and health of the people is the core of our actions since the foundation of our company. For over 120 years, this aspiration is the guiding principle of our employees. Our set of shared values enables us to achieve our ambitious goals together and expand STADA’s success in STADA ACQUIRES 15 WELL-ESTABLISHED GSK BRANDS 24/02/2020. Press Release. Acquisition of 15 well-established consumer healthcare brands across more than 40 countries and multiple therapeutic areas from GSK. The portfolio includes cold & flu, pain and skincare brands. STADA CEO Peter Goldschmidt: “This acquisition will further strengthen our position as a strong consumer healthcareplayer
LIDERIN® | STADA
Liderin® is a product for men. Its natural ingredients support sexual performance. It is a combination of ingredients of natural origin and essentials vitamins. RESPONSIBILITY AND SUSTAINABILITY In 1895, the founders of the Professional Community of German Pharmacists (STADA) set a goal to care for the well-being of its patients by preparing certain medicines in accordance with standardized guidelines. Since then, the preservation of society’s greatest asset, health, has been the focus of business activities throughout the Group.VENORUTON®
(only available in German) Venoruton® Intens. 500 mg Filmtabletten Poly(O-2-hydroxyethyl)rutosid Wirkstoff: Poly(O-2-hydroxyethyl)rutosid. Zur Anwendung bei Beschwerden in Folge von Erkrankungen der Beinvenen (chronische Veneninsuffizienz): Behandlung von Beinschwellungen (Ödemen) und Linderung bei schweren, müden Beinen, Spannungsgefühlen und Kribbeln. STADA TO ACQUIRE WALMARK Bad Vilbel, November 4, 2019 – STADA Arzneimittel AG (‘STADA’ or ‘the Group’) today announces the acquisition of Walmark a.s. (‘Walmark’ or ‘the company’) from Mid Europa Partners for an undisclosed consideration. Walmark is a leading manufacturer of Consumer Health products in Central Europe with a unique portfolio ofwell
STADA TO BECOME A MAJOR PHARMA PLAYER IN UKRAINE STADA Arzneimittel AG is a publicly-listed company with headquarters in Bad Vilbel, Germany. The company focuses on a two pillar strategy consisting of generics, including specialty pharmaceuticals and non-prescription consumer health products. Worldwide, STADA Arzneimittel AG sells its products in approximately 120 countries. STADA TO ACQUIRE BRANDED OTC PORTFOLIO FROM GSK TO Bad Vilbel, June 7, 2019 – The STADA Group continues to expand its Consumer Health business in Europe and selected markets in APAC and Latin America with a contract to acquire five skin care brands as well as a pediatric cough remedy from GlaxoSmithKline, completion of which is expected to occur in August 2019. STADA ACQUIRES UK BRANDED PRODUCT COMPANY NATURES AID STADA UK Holdings acquires Natures Aid, a privately-owned UK based branded product company, for a purchase price of GBP 18.5 million, including a net cash position of above GBP 1.5m. The company is an established manufacturer of vitamins, minerals, food supplements and herbal products distributed under the Natures Aid brand. STADA ARZNEIMITTEL AG This area also includes specialties like biosimilars. Worldwide, STADA Arzneimittel AG sells its products in approximately 120 countries. Consumer Healthcare brands such as Zoflora®, Grippostad®, Snup®, Aqualor®, Vitaprost® and Nizoral® are among the top sellers in their respective product categories.JOBS & CAREER
Caring for the well-being and health of the people is the core of our actions since the foundation of our company. For over 120 years, this aspiration is the guiding principle of our employees. Our set of shared values enables us to achieve our ambitious goals together and expand STADA’s success in OUR CORPORATE CULTURE This was the beginning of STADA’s impressive development. We are a leading manufacturer of high-quality pharmaceuticals. With a long-standing heritage rooted in pharmacies, we are a reliable and trustworthy partner for more than 120 years. With our products, we help people protect and regain a dignified and able life.INVESTOR RELATIONS
Internis Pharmaceuticals Ltd. Britannia Pharmaceuticals Ltd. Vietnam (3) Pymepharco JSC. STADA Vietnam. STADA Pharmaceuticals (Asia) Ltd Asia Pacific region. Investor & Creditor Relations. STADA-EURO-BOND 2015. In this area you can find information on the current STADA-EURO-BOND 2015. STADA FINANCIAL RESULTS STADA achieved 16% growth in reported Group sales to EUR 1.47 billion in the first half of 2020, with a 14% rise in adjusted EBITDA 1 to EUR 337 million, compared to the first half of 2019. 2; Reliable supplies of medicines throughout the pandemic, along with a constant flow of business-development transactions, bear testament to STADA’s purpose of caring for people’s health as aSTADA GROUP
STADA Group. Worldwide, STADA Arzneimittel AG sells its products in approximately 120 countries. All significant companies with a STADA share of at least 50% have been listed. Select a country for detailed information on the sales companies who operate within your selected territory. Back to country overview. RESPONSIBILITY AND SUSTAINABILITY In 1895, the founders of the Professional Community of German Pharmacists (STADA) set a goal to care for the well-being of its patients by preparing certain medicines in accordance with standardized guidelines. Since then, the preservation of society’s greatest asset, health, has been the focus of business activities throughout the Group. MANAGEMENT - SUPERVISORY BOARD STADA's Supervisory Board appoints the members of the Executive Board. Furthermore, the Supervisory Board monitors and advises the Executive Board in the running of its business operations. Through a regular dialogue with the Executive Board, the Supervisory Board is informed of the business development, strategy and company planning. STADA ARZNEIMITTEL AG Dieser Bereich umfasst auch Spezialpharmazeutika wie Biosimilars. Die STADA Arzneimittel AG vertreibt ihre Produkte weltweit in rund 120 Ländern. Consumer Healthcare Markenprodukte wie Zoflora®, Grippostad®, Snup®, Aqualor®, Vitaprost® und Nizoral® gehören zu den Topsellern in ihrer jeweiligen Produktkategorie. STADA ACQUIRES UK BRANDED PRODUCT COMPANY NATURES AID STADA UK Holdings acquires Natures Aid, a privately-owned UK based branded product company, for a purchase price of GBP 18.5 million, including a net cash position of above GBP 1.5m. The company is an established manufacturer of vitamins, minerals, food supplements and herbal products distributed under the Natures Aid brand. STADA ARZNEIMITTEL AG This area also includes specialties like biosimilars. Worldwide, STADA Arzneimittel AG sells its products in approximately 120 countries. Consumer Healthcare brands such as Zoflora®, Grippostad®, Snup®, Aqualor®, Vitaprost® and Nizoral® are among the top sellers in their respective product categories.JOBS & CAREER
Caring for the well-being and health of the people is the core of our actions since the foundation of our company. For over 120 years, this aspiration is the guiding principle of our employees. Our set of shared values enables us to achieve our ambitious goals together and expand STADA’s success in OUR CORPORATE CULTURE This was the beginning of STADA’s impressive development. We are a leading manufacturer of high-quality pharmaceuticals. With a long-standing heritage rooted in pharmacies, we are a reliable and trustworthy partner for more than 120 years. With our products, we help people protect and regain a dignified and able life.INVESTOR RELATIONS
Internis Pharmaceuticals Ltd. Britannia Pharmaceuticals Ltd. Vietnam (3) Pymepharco JSC. STADA Vietnam. STADA Pharmaceuticals (Asia) Ltd Asia Pacific region. Investor & Creditor Relations. STADA-EURO-BOND 2015. In this area you can find information on the current STADA-EURO-BOND 2015. STADA FINANCIAL RESULTS STADA achieved 16% growth in reported Group sales to EUR 1.47 billion in the first half of 2020, with a 14% rise in adjusted EBITDA 1 to EUR 337 million, compared to the first half of 2019. 2; Reliable supplies of medicines throughout the pandemic, along with a constant flow of business-development transactions, bear testament to STADA’s purpose of caring for people’s health as aSTADA GROUP
STADA Group. Worldwide, STADA Arzneimittel AG sells its products in approximately 120 countries. All significant companies with a STADA share of at least 50% have been listed. Select a country for detailed information on the sales companies who operate within your selected territory. Back to country overview. RESPONSIBILITY AND SUSTAINABILITY In 1895, the founders of the Professional Community of German Pharmacists (STADA) set a goal to care for the well-being of its patients by preparing certain medicines in accordance with standardized guidelines. Since then, the preservation of society’s greatest asset, health, has been the focus of business activities throughout the Group. MANAGEMENT - SUPERVISORY BOARD STADA's Supervisory Board appoints the members of the Executive Board. Furthermore, the Supervisory Board monitors and advises the Executive Board in the running of its business operations. Through a regular dialogue with the Executive Board, the Supervisory Board is informed of the business development, strategy and company planning. STADA ARZNEIMITTEL AG Dieser Bereich umfasst auch Spezialpharmazeutika wie Biosimilars. Die STADA Arzneimittel AG vertreibt ihre Produkte weltweit in rund 120 Ländern. Consumer Healthcare Markenprodukte wie Zoflora®, Grippostad®, Snup®, Aqualor®, Vitaprost® und Nizoral® gehören zu den Topsellern in ihrer jeweiligen Produktkategorie. STADA ACQUIRES UK BRANDED PRODUCT COMPANY NATURES AID STADA UK Holdings acquires Natures Aid, a privately-owned UK based branded product company, for a purchase price of GBP 18.5 million, including a net cash position of above GBP 1.5m. The company is an established manufacturer of vitamins, minerals, food supplements and herbal products distributed under the Natures Aid brand.COMPANY | STADA
The STADA Group. At STADA, we follow our purpose of “Caring for people’s health as a trusted partner”. In pursuit of this purpose, we are committed to further accelerating the successful trajectory of our company. STADA is a leading manufacturer of high-quality pharmaceuticals. With a long-standing heritage rooted in pharmacies,we are
ANNUAL REPORT 2020
Throughout the pandemic, STADA has been keen to support our healthcare professional partners around the world. Beyond the numerous targeted donation and support initiatives we have instigated, STADA wanted to personally say ‘thank you’ to all those working so hard on the front line to tackle and treat this terrible disease – not just doctors and nurses, but caregivers and communityINVESTOR RELATIONS
Internis Pharmaceuticals Ltd. Britannia Pharmaceuticals Ltd. Vietnam (3) Pymepharco JSC. STADA Vietnam. STADA Pharmaceuticals (Asia) Ltd Asia Pacific region. Investor & Creditor Relations. STADA-EURO-BOND 2015. In this area you can find information on the current STADA-EURO-BOND 2015.CONTACT | STADA
E-mail*. *. Phone. Fax. Subject*. *. I agree that any personal data may only be processed in accordance with the STADA privacy policy. You can access the data protection information obligations in accordance with Art. 13 GDPR here. Recapcha.PRESS RELEASES
05.03.2021. STADA attracts Bryan Kim as Global Head of Specialties. Experienced life sciences executive Bryan Kim will join STADA from 1st April 2021. Read more. 15.02.2021. STADA launches novel Parkinson’s therapy in Germany and Austria. In October, STADA acquired the rights to a triple combination product with the active ingredients STADA ACQUIRES 15 WELL-ESTABLISHED GSK BRANDS 24/02/2020. Press Release. Acquisition of 15 well-established consumer healthcare brands across more than 40 countries and multiple therapeutic areas from GSK. The portfolio includes cold & flu, pain and skincare brands. STADA CEO Peter Goldschmidt: “This acquisition will further strengthen our position as a strong consumer healthcareplayer
MANAGEMENT - SUPERVISORY BOARD STADA's Supervisory Board appoints the members of the Executive Board. Furthermore, the Supervisory Board monitors and advises the Executive Board in the running of its business operations. Through a regular dialogue with the Executive Board, the Supervisory Board is informed of the business development, strategy and company planning.STADA INSIGHTS
Working as a Portfolio Manager for Generics after successfully completing the graduate program at STADA in Germany, Collin shares insights on his career journey and greatest achievements. Find out what excites Collin about his current role and his favorite thing about STADA headquarters in Bad Vilbel. WOLFGANG OLLIG TO BECOME NEW CFO OF THE STADA GROUP Wolfgang Ollig to become new CFO of the STADA Group. Wolfgang Ollig to succeed Mark Keatley on 1 February 2020. Wolfgang has more than 15 years of experience as Group CFO in a variety of industries including medical and automotive. STADA CEO Peter Goldschmidt said: “Wolfgang’s deep knowledge in managing all financial aspects of aglobal
GESCHÄFTSBERICHT 2020 Lieferfähigkeit. Währungsbereinigter Umsatz 2020 3.010,3 Mio. €. Währungsbereinigtes EBITDA +15% in 2020. Operative Cash Flow 71% Cash Conversion Rate. Compliance unverändert: behördliche Inspektionen im Jahr 2020. Sicherheit in den Produktionsstätten gestiegen.en
*
Deutsch (DE)
123
* About STADA
* Products
* Investor Relations* Media
* Stories
* Career
* Contact
* Who we are
* Management
* Our Corporate Culture* STADA worldwide
* Company history
* Employees
* Responsibility and Sustainability* Compliance
About STADA
STADA worldwide
* Generics and Specialties * Consumer Health Products* Quality at STADA
* Adverse drug reaction report Consumer Health ProductsQuality at STADA
* At a Glance
* News
* Stock
* Bonds
* Financial Publications* Sustainability
* Calendar
* General Meeting
* Corporate Governance* IR Contact
Financial Calendar
Financial Publications* Newsroom
* Press Releases
* Press Photos
* Health Report
* Social Media
* Media Contact
Press Releases
Health Report 2020
* STADA Accelerate
* Learn more about STADA * Experience our culture * Discover your Opportunities* Get to know us
* How to find your dream job at STADA Experience our cultureCareer portal
*
en (Change Language)Back
* DEUTSCH
*
Select your country
Back
Websites worldwide
* Australia
* STADA Pharmaceuticals Australia Pty. Ltd * STADA Pharmaceuticals (Asia) Ltd Asia Pacific region* Austria
* STADA Arzneimittel GmbH * SCIOTEC Diagnostic Technologies GmbH* Belgium
* EG nv
* Bosnia-Herzegovina * Hemofarm Banja Luka d.o.o* China
* STADA Pharmaceuticals (Beijing) Ltd * STADA Pharmaceuticals (Asia) Ltd Asia Pacific region* Croatia
* STADA d.o.o.
* Czech Republic
* STADA PHARMA CZ, s.r.o.* Walmark a.s.
* Denmark
* STADA NORDIC ApS
* France
* EG LABO - Laboratoires Eurogenerics SAS* Germany
* ALIUD PHARMA® GmbH* STADA GmbH
* STADAPHARM GmbH
* Hemopharm GmbH Pharmazeutisches Unternehmen* Hungary
* STADA Hungary
* Ireland
* Clonmel Healthcare Limited* Italy
* EG S.p.A.
* Kazakhstan
* Nizhpharm-Kasachstan TOO DO* Lithuania
* UAB STADA-Nizhpharm-Baltija* Montenegro
* Hemomont d.o.o.
* Netherlands
* Centrafarm B.V.
* Healthypharm B.V.
* Poland
* STADA Poland Sp. z o.o.* Portugal
* Ciclum Farma, Unipessoal, LDA* Romania
* STADA M&D, Romania* Russia
* STADA CIS
* Serbia
* Hemofarm A.D.
* Slovakia
* STADA PHARMA Slovakia s.r.o* Slovenia
* STADA d.o.o.
* Spain
* Laboratorio STADA, S.L.* Switzerland
* Spirig HealthCare AG* Thailand
* STADA Pharmaceuticals (Asia) Ltd Asia Pacific region* The Phillippines
* STADA Pharmaceuticals (Asia) Ltd Asia Pacific region* Ukraine
* STADA Ukraine
* United Kingdom
* Natures Aid Ltd
* Thornton & Ross Ltd. * Internis Pharmaceuticals Ltd. * Britannia Pharmaceuticals Ltd* Vietnam
* Pymepharco JSC
* STADA Vietnam
* STADA Pharmaceuticals (Asia) Ltd Asia Pacific region* About STADA
* Products
* Investor Relations* Media
* Stories
* Career
* Contact
Back
* About STADA
* Who we are
* Management
* Our Corporate Culture* STADA worldwide
* Company history
* Employees
* Responsibility and Sustainability* Compliance
Back
* Products
* Generics and Specialties * Consumer Health Products* Quality at STADA
* Adverse drug reaction reportBack
* Investor Relations* At a Glance
* News
* Stock
* Bonds
* Financial Publications* Sustainability
* Calendar
* General Meeting
* Corporate Governance* IR Contact
Back
* Media
* Newsroom
* Press Releases
* Press Photos
* Health Report
* Social Media
* Media Contact
Back
Back
* Career
* STADA Accelerate
* Learn more about STADA * Experience our culture * Discover your Opportunities* Get to know us
* How to find your dream job at STADABack 123
Select your country
Australia
Austria
Belgium
Bosnia-Herzegovina
China
Croatia
Czech Republic
Denmark
France
Germany
Hungary
Ireland
Italy
Kazakhstan
Lithuania
Montenegro
Netherlands
Poland
Portugal
Romania
Russia
Serbia
Slovakia
Slovenia
Spain
Switzerland
Thailand
The Phillippines
Ukraine
United Kingdom
Vietnam
Websites worldwide
Select a country to go to the website of the respective STADA salescompany.
Australia (2)
* STADA Pharmaceuticals Australia Pty. Ltd * STADA Pharmaceuticals (Asia) Ltd Asia Pacific regionAustria (2)
* STADA Arzneimittel GmbH * SCIOTEC Diagnostic Technologies GmbHBelgium (1)
* EG nv
Bosnia-Herzegovina (1) * Hemofarm Banja Luka d.o.oChina (2)
* STADA Pharmaceuticals (Beijing) Ltd * STADA Pharmaceuticals (Asia) Ltd Asia Pacific regionCroatia (1)
* STADA d.o.o.
Czech Republic (2)
* STADA PHARMA CZ, s.r.o.* Walmark a.s.
Denmark (1)
* STADA NORDIC ApS
France (1)
* EG LABO - Laboratoires Eurogenerics SASGermany (4)
* ALIUD PHARMA® GmbH* STADA GmbH
* STADAPHARM GmbH
* Hemopharm GmbH Pharmazeutisches UnternehmenHungary (1)
* STADA Hungary
Ireland (1)
* Clonmel Healthcare LimitedItaly (1)
* EG S.p.A.
Kazakhstan (1)
* Nizhpharm-Kasachstan TOO DOLithuania (1)
* UAB STADA-Nizhpharm-BaltijaMontenegro (1)
* Hemomont d.o.o.
Netherlands (2)
* Centrafarm B.V.
* Healthypharm B.V.
Poland (1)
* STADA Poland Sp. z o.o.Portugal (1)
* Ciclum Farma, Unipessoal, LDARomania (1)
* STADA M&D, RomaniaRussia (1)
* STADA CIS
Serbia (1)
* Hemofarm A.D.
Slovakia (1)
* STADA PHARMA Slovakia s.r.oSlovenia (1)
* STADA d.o.o.
Spain (1)
* Laboratorio STADA, S.L.Switzerland (1)
* Spirig HealthCare AGThailand (1)
* STADA Pharmaceuticals (Asia) Ltd Asia Pacific region The Phillippines (1) * STADA Pharmaceuticals (Asia) Ltd Asia Pacific regionUkraine (1)
* STADA Ukraine
United Kingdom (4)
* Natures Aid Ltd
* Thornton & Ross Ltd. * Internis Pharmaceuticals Ltd. * Britannia Pharmaceuticals LtdVietnam (3)
* Pymepharco JSC
* STADA Vietnam
* STADA Pharmaceuticals (Asia) Ltd Asia Pacific region#HEALTHSTORIES
As part of our series #HealthStories, we spoke with Nico about why and how parkour inspires him and remains a passion.Read more
PARKINSON'S AWARENESS STADA launches campaign on World Parkinson's Day, 11 April.Read more
STADA FOCUSES EVEN MORE ON A FUTURE-ORIENTED GROWTH CULTURE Head of Global Human Resources Simone Berger moves up to STADA'sExecutive Board
Read more
STADA LAUNCHES NOVEL PARKINSON’S THERAPY IN GERMANY AND AUSTRIA STADA SHOWS RESILIENCE WITH DOUBLE-DIGIT GROWTH IN 2020Annual Report 2020
Read more
ANNUAL REPORT 2020
STADA Full Year 2020 ResultsRead more
*
*
*
*
*
*
EXPLORE OUR NEWS
30.03.2021
STADA strengthens oncology offering by launching bevacizumabbiosimilar
Read more
Press Release
11.03.2021
STADA continues to grow strongly during challenging timesAnnual Report 2020
Read more
Press Release
08.03.2021
Frankfurter Allgemeine Zeitung STADA wants to set the gold standardRead more
Press Release
08.03.2021
STADA launches medical cannabis for therapy of chronic pain patientsRead more
Press Release
05.03.2021
STADA attracts Bryan Kim as Global Head of Specialties Experienced life sciences executive Bryan Kim will join STADA from 1stApril 2021.
Read more
Press Release
05.03.2021
Handelsblatt
STADA enters the cannabis market - More acceptance for "therapy that is still stigmatised".Read more
Information
28.01.2021
#HealthStories: Take your TimeRead more
Health
STADA Health Report 2020 What do people in Europe think about treatments via webcam? What are the effects of COVID-19? What are views on compulsory vaccination? 24,000+ survey participants. Twelve countries. 30 questions. Caring for people’s health is STADA's purpose. This survey about future trends of health is based on our commitment to health.Read more
CORONAVIRUS INFORMATION CENTER The world has changed fighting the coronavirus disease (COVID-19). Our purpose “Caring for people's health as a trusted partner” is more valid than ever. Read more in our information hub about STADA's focus on keep supplying medicines to ensure patients get the medicines they need, intiatives and sources.Read more
GENERICS AND SPECIALTIES One of STADA's important business areas is the production and sales of inexpensive medicines that are generally known as generics. This area also includes specialties like biosimilars.Read more
CONSUMER HEALTHCARE PRODUCTS Worldwide, STADA Arzneimittel AG sells its products in approximately 120 countries. Consumer Healthcare brands such as Zoflora®, Grippostad®, Snup®, Aqualor®, Vitaprost® and Nizoral® are among the top sellers in their respective product categories.Read more
DIGITAL HEALTH KNOWLEDGE We are convinced that if you want to stay healthy, you cannot do without one thing: Health knowledge. Because of this, we have set ourselves the goal of raising awareness of health issues. Our blog "www.yourhealth.stada" offers helpful tips. Go to STADA Health BlogQUALITY AT STADA
Quality and responsibility to all who use our products or services is a fundamental part of our corporate strategy.Read more
COMPANY
STADA is a company with a focus on the healthcare market.Read more
*
*
> Our company truly values people on a personal level which inspires > me to grow and show my potential.Adam Valent
Global Product Manager BiosimilarsCAREER AT STADA
Are you looking for a job in a pharmaceutical company? Learn more about the STADA Group and the opportunities offered by an international company.Read more
CAREER AT STADA
Are you looking for a job in a pharmaceutical company? Learn more about the STADA Group and the opportunities offered by an international company.Read more
> Our company truly values people on a personal level which inspires > me to grow and show my potential.Adam Valent
Global Product Manager Biosimilars Newsletter Corporate NewsTop Products
* Zoflora®
* Grippostad®
* SNUP®
* Aqualor®
* Vitaprost®
* Nizoral®
* Ladival®
* Covonia®
Top Products
* Zoflora®
Zoflora®
Zoflora® is a disinfectant to keep households safe from harmfulbacteria.
Zoflora®
* Grippostad®
Grippostad®
Grippostad® C is a medicine against flu infections and colds.Grippostad®
* SNUP®
Snup®
SNUP® spray is a medicine for the decongestion of colds.SNUP®
* Aqualor®
Aqualor®
Aqualor® for the self-medication of sinusitis and sore throat.Aqualor®
* Vitaprost®
Vitaprost®
Vitaprost® is the medication used for Prostate diseaseVitaprost®
* Nizoral®
Nizoral®
Nizoral® is a medical treatment against dandruff.Nizoral®
* Ladival®
Ladival®
Ladival® offers sun protection with a range that is suitable foreveryone.
Ladival®
* Covonia®
Covonia®
Covonia® offers a range of options, whether you are looking for a cough medicines or lozenges.Covonia®
Company
* About us
* Products
* Investor & Creditor Relations* Media
* Career
* STADA Worldwide
Company
* About us
* Products
* Investor & Creditor Relations* Media
* Career
* STADA Worldwide
Get in Touch
*
Contact
*
info@stada.de
*
+49 6101 603-0
FOLLOW US
Conditions of Use
Privacy Policy
Imprint
Cookie Settings
Copyright STADA Arzneimittel AG 2021 Your Privacy Settings This website uses cookies and similar technologies to provide you with the best service possible and to display advertising and other content that is in line with your interests on our website, social media and partner websites. We respect your privacy and only process data for functional and marketing purposes when you give us your consent by clicking on “OK”. You can amend or revoke your cookie preferences at any time in the privacy settings . Details can be found in our Data Protection Declaration .OK
Decline
Individual
Powered by
Usercentrics Consent Management Platform Logo Imprint | Privacy PolicyDetails
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0